International validation of CoEHAR studies: fewer Covid-19 hospitalization among smokers and studies on the role of nicotine

Direct causal relationship between smoking and COVID-19 outcomes: the work of CoEHAR researchers finds confirmations in an english cohort study. Compared with people who had never smoked, current smoking was associated with one-third lower risk of hospitalization

Continue ReadingInternational validation of CoEHAR studies: fewer Covid-19 hospitalization among smokers and studies on the role of nicotine

Smokers and Covid-19 risk: a new CoEHAR study confirms that vaccines are less effective on smokers

According to the researchers from CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, in partnership with the University of Pavia and the University of Milan “Statale”, the analysis of the international studies conducted on the humoral response to Covid-19 vaccines confirmed the negative impact of smoking on antibodies levels induced by vaccine and the rapid lowering of the vaccine-elicited IgG titres over six months

Continue ReadingSmokers and Covid-19 risk: a new CoEHAR study confirms that vaccines are less effective on smokers

The geography of Harm Reduction: while snus and chewing tobacco are distributed worldwide, the literature is incomplete and deceiving

The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa

Continue ReadingThe geography of Harm Reduction: while snus and chewing tobacco are distributed worldwide, the literature is incomplete and deceiving